Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

• 作者: Canrong Wu Hua Li Lixia Chen Mengzhu Zheng Mingxue Li Peng Zhang Qiqi Wang Wu Zhong Xingzhou Li Yali Wang Yang Liu Yang Xu Yueying Yang
• 来源期刊: 药学学报（英文版）
• 关键词: SARS-CoV-2 Drug repurposing Molecular docking Remdesivir Homology modeling
• 年，卷（期）: 2020,（5）
• 页码范围: 766-788
• 页数: 23页
• 语种: 英文

摘要

SARS-CoV-2 has caused tens of thousands of infections and more than one thousand deaths.There are currently no registered therapies for treating coronavirus infections.Because of time consuming process of new drug development,drug repositioning may be the only solution to the epidemic of sudden infectious diseases.We systematically analyzed all the proteins encoded by SARS-CoV-2 genes,compared them with proteins from other coronaviruses,predicted their structures,and built 19 structures that could be done by homology modeling.By performing target-based virtual ligand screening,a total of 21 targets (including two human targets) were screened against compound libraries including ZINC drug database and our own database of natural products.Structure and screening results of important targets such as 3-chymotrypsin-like protease (3CLpro),Spike,RNA-dependent RNA polymerase (RdRp),and papain like protease (PLpro) were discussed in detail.In addition,a database of 78 commonly used antiviral drugs including those currently on the market and undergoing clinical trials for SARS-CoV-2 was constructed.Possible targets of these compounds and potential drugs acting on a certain target were predicted.This study will provide new lead compounds and targets for further in vitro and in vivo studies of SARS-CoV-2,new insights for those drugs currently ongoing clinical studies,and also possible new strategies for drug repositioning to treat SARS-CoV-2 infections.